Correlation between Platelet to Lymphocyte Ratio with C-Reactive Protein in COVID-19 Patients
DOI:
https://doi.org/10.24293/ijcpml.v28i1.1750Keywords:
Platelet to lymphocyte ratio, C-reactive protein, COVID-19Abstract
Coronavirus 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Inflammation occurs when the body is infected with the virus. Platelets play a role in immune response and immunomodulation by activating P-Selectin Glycoprotein (PSGL) to the site of inflammation. Lymphocytes play a role through CD4 T-cells, B-cells producing specific viral antibodies, and CD8 cytotoxic T-cells by directly killing the virus in infected cells. This study aimed to prove the correlation between PLR and CRP as inflammation markers in COVID-19 patients. This study was a retrospective observational study with the cross-sectional approach at Dr. Kariadi Hospital, Semarang, for the period March-August 2020. Spearman test performed for analyzing data with p<0.05 was significant. Thirty-three confirmed COVID-19 patients with median value of PLR 218 (103-1609) and CRP 15.94 (1.24-200) mg/L were tested for correlation with a value of p=0.013 and r=0.427. The increase of PLR and CRP in COVID-19 patients was caused by an inflammatory process mediated by the immune response. High values in the blood were associated with disease severity and poor prognosis. There was a statistically significant moderate positive correlation between PLR and CRP in COVID-19 patients.
Downloads
References
Kementerian Kesehatan Republik Indonesia. Pedoman pencegahan dan pengendalian Coronavirus Disease (COVID-19) Rev-5, Juli 2020, Jakarta, Kementerian Kesehatan RI, 2020; 214.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Sinto R, et al. Coronavirus disease 2019:
Tinjauan literatur terkini Coronavirus disease 2019: Review of current literatures. J Penyakit Dalam
Indonesia, 2020; 7(1): 45-67.
Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors following stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol, 2015; 10(2): 280–285.
Harun H, Bahrun U, Darmawaty. Platelet Lymphocyte Ratio (PLR) markers in acute coronary syndrome. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2016; 23(1): 7-11.
Marques R, Carias E, Domingos A, Guedes A, Bernardo I, Neves P. Prognostic value of lymphocyte cell ratios in peritoneal dialysis. Port J Nephrol Hypert, 2021; 35(1): 18-21.
Yang Ping A, Liu Ping J, Tao Qiang W, Li Ming H. The diagnostic and predictive role of NLR, d-NLR,
and PLR in COVID-19 patients. International Immunopharmacology, 2020; 84: 1-7.
Lee Han J, Song S, Yoon Young S, Lim C, Song J, Kim H. Neutrophil to lymphocyte ratio and platelet to
lymphocyte ratio as diagnostic marker for pneumonia severity. British Journal of Biomedical Science, 2016; 73(3): 140-142.
Qu R, Ling Y, Zhang Y, Wei L, Chen X, et al. Platelet to lymphocyte ratio is associated with prognosis in
patients with Coronavirus disease-19. Journal of Medical Virology, 2020; 1-9.
Kartal O, Kartal AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia.
Bratisl Med J, 2017; 118(9): 513-516.
Koupenova M, Corkey H, Vitseva O, Manni G, Pang C, et al. The role of platelets in mediating a response to human influenza infection. Nature Communication, 2019; 10(1780): 1-18.
Martini C, Thompson E, Hyslop S, Cockshell M, Dale B, et al. Platelets disrupt vasculogenic mimicry by cancer cells. Nature, 2020; 10(5869): 1-18.
Behrens K, Alexander W. Cytokine control of megakaryopoiesis. Growth Factors, 2018; 1-15.
Ribeiro L, Branco L, Franklin B. Regulation of innate immune responses by platelets. Frontiers in
Immunology, 2019; 10(1320): 1-9.
Uslu AU, Kucuk A, Sahin A, Ugan Y, Yilmaz R, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Neutrophil lymphocyte ratio and platelet to lymphocyte ratio. Int J Rheum Dis, 2015; 18: 731-735.
Li G, Fan Y, Lai Y, Han T, Li Z, et al. Coronavirus infections and immune responses. J Med Virol, 2020;
(4): 424–32.
Chen J, Lau Y, Lamirande E, Paddock C, Barlett J, Zaki S et al. Cellular immune responses to severe acute respiratory syndrome Coronavirus (SARS-CoV) + infection in senescent BALB/c mice: CD4 T-cells are important in control of SARS-CoV infection. Journal of Virology, 2010; 84(3): 1-13.
Shen Y, Huang X, Zhang W. Platelet to lymphocyte ratio as a prognostic predictor of mortality for sepsis: Interaction effect with disease severity-a retrospective study. BMJ, 2018; 1-7.
Abigail SC, Rout A. Use of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19. Journal of Clinical Medical Research, 2020; 12(7): 448-453.
Daniel MS, Pandita B, Ananta ME, Tango T. Platelet to lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. Journal of the Intensive Care
Society, 2020; 0(0): 1-7.
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Annals of Hematology, 2020; 99: 1205-1208.
Sproston N, Ashworth J. Role of C-reactive protein at sites of inflammation and infection. Frontiers in
Immunology, 2018; 9(754): 1-11.
Stringer D, Braude P, Myint P, Evans L, Collins J, et al. The role of C-reactive protein as a prognostic marker in COVID-19. International Journal of Epidemiology, 2021; 50(2): 420-429.
Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab F, et al. C-reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One, 2020; 15(11): 1-10.
Liu F, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. Journal of Clinical Virology, 2020; 127: 1-5.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
